Te
Associate Director, Facilities & Workplace Excellence
Teva Pharmaceuticals
Full-time
Zagreb, Croatia
other-general
Posted:
February 21, 2026
Location:
Zagreb, Croatia, Croatia
Job Description
Associate Director, Facilities & Workplace Excellence
Date: Feb 26, 2026
Location:
Zagreb, Croatia, 10000
Company: Teva Pharmaceuticals
Job Id: 65855
**We Are Teva**
We’re Teva, a leading innovative biopharmaceutical company, enabled by a world-class generics business. Whether it’s innovating in the fields of neuroscience and immunology or delivering high-quality medicine worldwide, we’re dedicated to addressing patients’ needs now and in the future. Here, you will be part of a high-performing, inclusive culture that values fresh thinking and collaboration. You'll have the room to grow, the flexibility to balance life with work, and the opportunity to better health worldwide, together.
**The opportunity**
The Associate Director, Centre of Excellence (FM/RE) - Facilities & Workplace Excellence plays a pivotal role in shaping and...
Date: Feb 26, 2026
Location:
Zagreb, Croatia, 10000
Company: Teva Pharmaceuticals
Job Id: 65855
**We Are Teva**
We’re Teva, a leading innovative biopharmaceutical company, enabled by a world-class generics business. Whether it’s innovating in the fields of neuroscience and immunology or delivering high-quality medicine worldwide, we’re dedicated to addressing patients’ needs now and in the future. Here, you will be part of a high-performing, inclusive culture that values fresh thinking and collaboration. You'll have the room to grow, the flexibility to balance life with work, and the opportunity to better health worldwide, together.
**The opportunity**
The Associate Director, Centre of Excellence (FM/RE) - Facilities & Workplace Excellence plays a pivotal role in shaping and...
Apply for this Job
Submit your application for the Associate Director, Facilities & Workplace Excellence position at Teva Pharmaceuticals.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
Zagreb, Croatia
Posted:
February 21, 2026
Deadline:
March 26, 2026